The global transcatheter mitral valve market is on a strong growth trajectory, with projections estimating a market valuation of USD 1.6 billion by the end of 2024 and an impressive compound annual ...

MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...

Accordingly, we prefer valve replacement as the treatment of choice for severe mitral regurgitation secondary to ruptured chordae tendineae. Thirty-nine cases of severe mitral regurgitation ...

the world's first transcatheter mitral valve replacement system, which will benefit many patients with mitral regurgitation who have limited treatment options. This breakthrough technology ...

(n=324); patients with moderate or severe mitral stenosis were excluded from the trial. Baseline characteristics, efficacy and safety outcomes were compared between each type and no significant VHD.

2D transthoracic echocardiography showed bi-atrial enlargement with thickened mitral and tricuspid valves with severe mitral and tricuspid stenosis. Due to refractory shock despite medical management, ...

New data from a large, international registry showed balloon-assisted anterior mitral leaflet modification (BATMAN) was safe, ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...